BioTuesdays

Category - Markets

ConforMIS

BTIG ups Conformis PT to $4.50 from $3

BTIG raised its price target for Conformis (NASDAQ:CFMS) to $4.50 from $3 after the company arranged $33-million in debt and equity financing from Innovatus Capital Partners and East West Bank. The stock closed at $3.84...

SVB Leerink cuts Aduro Biotech PT to $5 from $8

SVB Leerink reduced its price target for Aduro Biotech (NASDAQ:ADRO) to $5 from $8 based on recent ADU-S100 (MIW815) Phase1b dose escalation data presentation at ASCO and re-evaluation of development assumptions in the...

Acer Therapeutics

WB cuts Acer Therapeutics to MP from OP

William Blair downgraded Acer Therapeutics (NASDAQ:ACER) to “market perform” from “outperform” after the company received a complete response letter from the FDA for its lead product, Edsivo (celiprolol).

Krystal Biotech Logo

HCW ups Krystal Biotech PT to $56 from $38

H.C. Wainwright raised its price target for Krystal Biotech (NASDAQ:KRYS) to $56 from $38 after the company posted positive results from its GEM-2 study, a Phase 2 clinical trial of KB103 in patients with recessive...